These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3889 related articles for article (PubMed ID: 6696407)

  • 41. [Isolation of anthranilic acid derivatives from sibiromycin inactivation products].
    Rubasheva LM; Mezentsev AS; Vlasova TF; Anisimova OS
    Antibiotiki; 1973 Mar; 18(3):216-8. PubMed ID: 4764217
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemotherapy on Harding-Passey melanoma with gladenine. Part I.
    Sokoloff B; Araki K; Valcarce N; Sokoloff AH; Brown JH
    Growth; 1976 Jun; 40(2):163-9. PubMed ID: 1278712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. II. Isolation and characterization.
    Leet JE; Schroeder DR; Krishnan BS; Matson JA
    J Antibiot (Tokyo); 1990 Aug; 43(8):961-6. PubMed ID: 2211363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor activity of kijanimicin.
    Bradner WT; Claridge CA; Huftalen JB
    J Antibiot (Tokyo); 1983 Aug; 36(8):1078-9. PubMed ID: 6630059
    [No Abstract]   [Full Text] [Related]  

  • 45. [A new species of the genus Micropolyspora and its antibiotic properties].
    Preobrazhenskaia TP; Ukholina RS; Nechaeva NP; Filicheva VA; Gavrilina GV
    Antibiotiki; 1973 Nov; 18(11):963-8. PubMed ID: 4801773
    [No Abstract]   [Full Text] [Related]  

  • 46. [Morphological properties of the producer of the antineoplastic antibiotic sibiromycin: Streptosporangium sibiricum Gause et al., 1969, in submerged cultures].
    Ivanitskaia LP
    Antibiotiki; 1971 Mar; 16(3):233-6. PubMed ID: 5558684
    [No Abstract]   [Full Text] [Related]  

  • 47. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 48. Renastacarcin, a novel antitumor substance produced by Streptomyces.
    Sasaki T; Otake N
    J Antibiot (Tokyo); 1975 Jul; 28(7):552-4. PubMed ID: 1150546
    [No Abstract]   [Full Text] [Related]  

  • 49. Kettapeptin: isolation, structure elucidation and activity of a new hexadepsipeptide antibiotic from a terrestrial Streptomyces sp.
    Maskey RP; Fotso S; Sevvana M; Usón I; Grün-Wollny I; Laatsch H
    J Antibiot (Tokyo); 2006 May; 59(5):309-14. PubMed ID: 16883782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New beta-class milbemycin compound from Streptomyces avermitilis NEAU1069: fermentation, isolation and structure elucidation.
    Wang M; Yang XH; Wang JD; Wang XJ; Chen ZJ; Xiang WS
    J Antibiot (Tokyo); 2009 Oct; 62(10):587-91. PubMed ID: 19680282
    [No Abstract]   [Full Text] [Related]  

  • 51. Lavanducyanin, a new antitumor substance produced by Streptomyces sp.
    Imai S; Furihata K; Hayakawa Y; Noguchi T; Seto H
    J Antibiot (Tokyo); 1989 Jul; 42(7):1196-8. PubMed ID: 2753825
    [No Abstract]   [Full Text] [Related]  

  • 52. [Action of N-nitrosomethylurea on antitumor antibiotic-resistent substrains of Fisher L-5178 lymphadenosis].
    Minenkova EA; Fomina MM; Evseenko LS
    Izv Akad Nauk SSSR Biol; 1980; (1):54-61. PubMed ID: 7358895
    [No Abstract]   [Full Text] [Related]  

  • 53. [Physicochemical and biological properties of bleomycin complex antibiotics].
    Zenkova VA; Iurina MS; Lomakina NN; Gol'dberg LE; Bazhanov VS
    Antibiotiki; 1979 Mar; 24(3):175-9. PubMed ID: 87144
    [No Abstract]   [Full Text] [Related]  

  • 54. Biosynthetic capacities of actinomycetes. 4. Echinoserine, a new member of the quinoxaline group, produced by Streptomyces tendae.
    Blum S; Fielder HP; Groth I; Kempter C; Stephan H; Nicholson G; Metzger JW; Jung G
    J Antibiot (Tokyo); 1995 Jul; 48(7):619-25. PubMed ID: 7649858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genoketides A1 and A2, new octaketides and biosynthetic intermediates of chrysophanol produced by Streptomyces sp. AK 671.
    Fiedler HP; Dieter A; Gulder TA; Kajahn I; Hamm A; Brown R; Jones AL; Goodfellow M; Müller WE; Bringmann G
    J Antibiot (Tokyo); 2008 Jul; 61(7):464-73. PubMed ID: 18776659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitocromin: an antibiotic with antitumor activity.
    Liu WC; Cullen WP; Rao KV
    J Antibiot (Tokyo); 1969 Dec; 22(12):608-11. PubMed ID: 5367394
    [No Abstract]   [Full Text] [Related]  

  • 57. [Isolation and structure of the active component of the antitumor agent blastolysin].
    Bezrukov MV; Andronova TM; Reshetova OS; Mal'kova VP; Sorokina IB
    Bioorg Khim; 1987 Mar; 13(3):386-94. PubMed ID: 3593429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro methods used in detection and quantitation of antitumor drugs produced by microbial fermentations.
    Hanka LJ; Martin DG; Neil GL
    Lloydia; 1978; 41(2):85-97. PubMed ID: 651563
    [No Abstract]   [Full Text] [Related]  

  • 60. [Bleomycin, a new antibiotic possessing antitumor properties].
    Vermel' EM
    Vopr Onkol; 1972; 18(9):85-93. PubMed ID: 4126161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 195.